Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06049745
PHASE4

Use of Misoprostol in Hysteroscopic Myomectomy

Sponsor: Assuta Ashdod Hospital

View on ClinicalTrials.gov

Summary

Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.

Official title: Use of Misoprostol in Hysteroscopic Myomectomy, a Randomized Peospective Trial

Key Details

Gender

FEMALE

Age Range

20 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2023-11

Completion Date

2026-10

Last Updated

2023-09-22

Healthy Volunteers

Yes

Interventions

DRUG

Misoprostol 400 Microgram Oral Tablet

S.L misoprostol 400 mcg

Locations (1)

Assuta Ashdod University Hospital

Ashdod, Israel